Chemomab Therapeutics Ltd. Share-based Payment Arrangement, Expense
Chemomab Therapeutics Ltd. (CMMB) reported Share-based Payment Arrangement, Expense of $623.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-23
- Chemomab Therapeutics Ltd. share-based payment arrangement, expense for fiscal 2020 was $130.00K, a 88.77% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. share-based payment arrangement, expense for fiscal 2019 was $1.16M, a 39.88% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. share-based payment arrangement, expense for fiscal 2018 was $1.93M.
| Period end | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $623.00K 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $245.00K 6-K · filed 2025-08-14 | ||
| 2024-12-31 | $617.00K 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $355.00K 6-K · filed 2025-08-14 | ||
| 2023-12-31 | $1.49M 20-F · filed 2026-03-23 | ||
| 2022-12-31 | $3.21M 20-F · filed 2025-04-04 | ||
| 2021-12-31 | $2.02M 20-F · filed 2024-03-28 | ||
| 2020-12-31 | $130.00K 10-K · filed 2022-03-30 | -$20.00K 10-K · filed 2021-03-09 | |
| 2019-12-31 | $1.16M 10-K · filed 2021-03-09 | ||
| 2018-12-31 | $1.93M 10-K · filed 2020-03-17 |